These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

202 related articles for article (PubMed ID: 27232507)

  • 1. Does HIV Influence Hepatitis C Cure Rates Using Direct-Acting Antivirals?
    de Mendoza C
    AIDS Rev; 2016; 18(2):112-3. PubMed ID: 27232507
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Successful sofosbuvir-based therapy in HIV/hepatitis C virus coinfected liver transplant recipients with recurrent hepatitis C virus infection.
    Grant JL; Hawkins C; Brooks H; Palella FJ; Koppe SW; Abecassis MM; Stosor V
    AIDS; 2016 Jan; 30(1):93-8. PubMed ID: 26731756
    [TBL] [Abstract][Full Text] [Related]  

  • 3. HIV and HCV Therapies in 2016: Optimal Regimens.
    Sasadeusz J
    AIDS Rev; 2016; 18(4):212-221. PubMed ID: 27438581
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Treatment of hepatitis C in HIV-coinfected patients.
    Hughes CA; Shafran SD
    Ann Pharmacother; 2006 Mar; 40(3):479-89; quiz 582-3. PubMed ID: 16507622
    [TBL] [Abstract][Full Text] [Related]  

  • 5. HIV/HCV coinfection: a new era of treatment.
    Highleyman L
    BETA; 2011; 23(4):30-47. PubMed ID: 22567825
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Drug interactions of hepatitis C direct-acting antivirals in the HIV-infected person.
    El-Sherif O; Back D
    Curr HIV/AIDS Rep; 2015 Sep; 12(3):336-43. PubMed ID: 26159742
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Hepatitis C and HIV Coinfection for Social Workers in Public Health, Medical and Substance Use Treatment Settings.
    Sims OT; Womack BG
    Soc Work Public Health; 2015; 30(4):325-35. PubMed ID: 25811121
    [TBL] [Abstract][Full Text] [Related]  

  • 8. HIV Coinfected Have Similar SVR Rates as HCV Monoinfected With DAAs: It's Time to End Segregation and Integrate HIV Patients Into HCV Trials.
    Shafran SD
    Clin Infect Dis; 2015 Oct; 61(7):1127-34. PubMed ID: 26060286
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Management of Hepatitis C/HIV Coinfection in the Era of Highly Effective Hepatitis C Virus Direct-Acting Antiviral Therapy.
    Wyles DL; Sulkowski MS; Dieterich D
    Clin Infect Dis; 2016 Jul; 63 Suppl 1(Suppl 1):S3-S11. PubMed ID: 27363438
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pharmacologic Considerations in the Treatment of Hepatitis C Virus in Persons With HIV.
    MacBrayne CE; Kiser JJ
    Clin Infect Dis; 2016 Jul; 63 Suppl 1(Suppl 1):S12-23. PubMed ID: 27363437
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Management of hepatitis C virus coinfection in HIV-infected persons.
    O'Leary JG; Chung RT
    AIDS Read; 2006 Jun; 16(6):313-6, 318-20. PubMed ID: 16795921
    [TBL] [Abstract][Full Text] [Related]  

  • 12. HIV and hepatitis C coinfection.
    Matthews GV; Dore GJ
    J Gastroenterol Hepatol; 2008 Jul; 23(7 Pt 1):1000-8. PubMed ID: 18707597
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Optimal therapy of HIV/HCV co-infected patients with direct acting antivirals.
    Rockstroh JK
    Liver Int; 2015 Jan; 35 Suppl 1():51-5. PubMed ID: 25529087
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Directly acting antivirals for hepatitis C virus arrive in HIV/hepatitis C virus co-infected patients: from 'mind the gap' to 'where's the gap?'.
    Childs K; Taylor C; Dieterich D; Agarwal K
    AIDS; 2016 Apr; 30(7):975-89. PubMed ID: 26836785
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Hepatitis C Virus in the HIV-infected patient.
    Andersson K; Chung RT
    Clin Liver Dis; 2006 May; 10(2):303-20, viii. PubMed ID: 16971263
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Simeprevir for the treatment of hepatitis C and HIV/hepatitis C co-infection.
    Flanagan S; Crawford-Jones A; Orkin C
    Expert Rev Clin Pharmacol; 2014 Nov; 7(6):691-704. PubMed ID: 25209158
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Differences in virological response to pegylated interferon and ribavirin between hepatitis C virus (HCV)-monoinfected and HCV-HIV-coinfected patients.
    Tural C; Galeras JA; Planas R; Coll S; Sirera G; Giménez D; Salas A; Rey-Joly C; Cirera I; Márquez C; Tor J; Videla S; García-Retortillo M; Clotet B; Solà R
    Antivir Ther; 2008; 13(8):1047-55. PubMed ID: 19195330
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Interferon-free therapy in hepatitis C virus (HCV) monoinfected and HCV/HIV coinfected patients: effect on cognitive function, fatigue, and mental health.
    Kleefeld F; Heller S; Ingiliz P; Jessen H; Petersen A; Kopp U; Kraft A; Hahn K
    J Neurovirol; 2018 Oct; 24(5):557-569. PubMed ID: 29785584
    [TBL] [Abstract][Full Text] [Related]  

  • 19. HIV and hepatitis C virus coinfection: bad bedfellows.
    Schooley RT
    Top HIV Med; 2005; 13(4):112-6. PubMed ID: 16304454
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Treatment of hepatitis C virus/HIV coinfection.
    Chun S; Sherman KE
    Clin Liver Dis; 2005 Aug; 9(3):525-33, ix. PubMed ID: 16023981
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.